MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 47 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 61.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,523 | +19.2% | 27,588 | +9.6% | 0.00% | 0.0% |
| Q2 2023 | $71,752 | -27.7% | 25,176 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $99,193 | -0.5% | 25,176 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $99,697 | -93.2% | 25,176 | -84.1% | 0.00% | -94.6% |
| Q3 2022 | $1,459,000 | +48.4% | 158,752 | -0.7% | 0.04% | +48.0% |
| Q2 2022 | $983,000 | -16.9% | 159,801 | -13.2% | 0.02% | -10.7% |
| Q1 2022 | $1,183,000 | +3.5% | 184,198 | +5.6% | 0.03% | +3.7% |
| Q4 2021 | $1,143,000 | +14.8% | 174,463 | 0.0% | 0.03% | -3.6% |
| Q3 2021 | $996,000 | -19.4% | 174,463 | -22.4% | 0.03% | -30.0% |
| Q2 2021 | $1,236,000 | +2.5% | 224,758 | +7.9% | 0.04% | -11.1% |
| Q1 2021 | $1,206,000 | -13.6% | 208,332 | 0.0% | 0.04% | -13.5% |
| Q4 2020 | $1,396,000 | -4.1% | 208,332 | +4.8% | 0.05% | -40.9% |
| Q3 2020 | $1,455,000 | +703.9% | 198,708 | +315.7% | 0.09% | +633.3% |
| Q2 2020 | $181,000 | – | 47,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |